Mattel launches new Barbie dolls with autism, blindness, vitiligo for inclusive representation

By Folashade Olorunfemi –
American toy producer and entertainment company Mattel has once again demonstrated its commitment to global diversity and inclusivity, launching its debut autistic Barbie doll. The release expands its Fashionistas line, which already includes dolls with Down syndrome, a blind Barbie, and Barbie and Ken figures with vitiligo.
The doll was developed over 18 months in partnership with the Autistic Self Advocacy Network, a nonprofit that advocates for the rights and better media representation of autistic people. Mattel said the aim was to create a Barbie that reflects some ways autistic individuals may experience and process the world.
Designing the doll presented challenges due to the wide range of traits and behaviours autism encompasses, many of which are not immediately visible. Noor Pervez, a representative of the advocacy network, noted that while autistic behaviours vary, the doll highlights some common expressions.
The new Barbie’s features include eyes slightly shifted to the side, reflecting how some autistic people may avoid direct eye contact, and articulated elbows and wrists to acknowledge stimming behaviours like hand flapping and blinking that aid sensory regulation.
Clothing choices were also carefully considered. The final design includes an A-line dress with short sleeves and a flowy skirt to reduce fabric-to-skin contact, along with flat shoes for comfort and stability. Accessories include a pink finger-clip fidget spinner, noise-canceling headphones, and a pink tablet modelled after communication devices used by non-verbal autistic individuals.
Mattel has rapidly expanded the Fashionistas line in recent years, introducing dolls representing Type 1 diabetes, prosthetic limbs, hearing aids, and a wide range of body types, skin tones, and hair textures.
According to the US Centers for Disease Control and Prevention (CDC), autism affects about one in 31 eight-year-old children in the United States, with higher diagnosis rates among boys and prevalence varying across racial and ethnic groups.







